von Ehrenstein O S, Maier E M, Weiland S K, Carr D, Hirsch T, Nicolai T, Roscher A A, von Mutius E
University Children's Hospital, Munich, Germany.
Arch Dis Child. 2004 Mar;89(3):230-1. doi: 10.1136/adc.2002.023614.
In a random sample of children (aged 9-11 years; n = 5629), who were studied according to the ISAAC phase II protocol, heterozygosity of the alpha1 antitrypsin (alpha1-AT) Pi genotypes MS or MZ, or low alpha1-AT plasma levels, were not associated with an increased risk of developing asthma. Asthmatics with low levels of alpha1-AT were particularly prone to develop airway hyperresponsiveness and reduced lung function.
在一项按照国际儿童哮喘和变应性疾病研究(ISAAC)第二阶段方案进行研究的儿童随机样本(9至11岁;n = 5629)中,α1抗胰蛋白酶(α1-AT)Pi基因型MS或MZ的杂合性,或α1-AT血浆水平较低,与患哮喘风险增加无关。α1-AT水平较低的哮喘患者尤其容易出现气道高反应性和肺功能下降。